CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers - Markert, Christoph; Burhenne, Jürgen; Weiß, Johanna; Mikus, Gerd; Haefeli, Walter E. (Clinical pharmacology & therapeutics, 2014)
Gesehen am 23.02.2015